Scotiabank analyst Greg Harrison raised the firm’s price target on BridgeBio (BBIO) to $49 from $48 and keeps an Outperform rating on the ...
Palantir produced $2.8 billion in revenues in 2024, far and above BBAI’s $165 million. While that’s not a dealbreaker, ...
BNP Paribas, took a look at possible extreme scenarios investors should consider for 2025, like a 40% stock drop.
A €120 million provision in the bank’s accounts for UK motor finance risk is to recorded in the 2024 financial year as it has ...